BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18549004)

  • 1. Thanks, but no thanks.
    Bell H
    Minn Med; 2008 Apr; 91(4):26-30. PubMed ID: 18549004
    [No Abstract]   [Full Text] [Related]  

  • 2. Physician-industry relations--will fewer gifts make a difference?
    Steinbrook R
    N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry gifts: dos and don'ts.
    Stirewalt K
    Minn Med; 2012 Jan; 95(1):32. PubMed ID: 22355909
    [No Abstract]   [Full Text] [Related]  

  • 4. The baby with the bathwater.
    Buyske J
    Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
    [No Abstract]   [Full Text] [Related]  

  • 5. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.
    Greenland P
    Arch Intern Med; 2009 May; 169(9):829-31. PubMed ID: 19433693
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiology and industry: can this relationship be saved?
    Forman HP
    J Am Coll Radiol; 2006 May; 3(5):333-4. PubMed ID: 17412076
    [No Abstract]   [Full Text] [Related]  

  • 7. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
    Wilson A
    Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
    [No Abstract]   [Full Text] [Related]  

  • 8. Biased articles.
    Friedman JH
    Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
    [No Abstract]   [Full Text] [Related]  

  • 9. Politely refuse the pen and note pad: gifts from industry to physicians harm patients.
    Iserson KV; Cerfolio RJ; Sade RM
    Ann Thorac Surg; 2007 Oct; 84(4):1077-84. PubMed ID: 17888951
    [No Abstract]   [Full Text] [Related]  

  • 10. Gifts. What's all the fuss about?
    Murray D
    Med Econ; 2002 Oct; 79(19):119-20. PubMed ID: 12407814
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 12. US campaign aims to end industry gifts, speaking fees, and travel for doctors.
    Tanne JH
    BMJ; 2007 Feb; 334(7590):385. PubMed ID: 17322228
    [No Abstract]   [Full Text] [Related]  

  • 13. The death of common sense.
    Trachtman H
    Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
    [No Abstract]   [Full Text] [Related]  

  • 14. Large or small, a gift is a gift is a gift.
    Paris JJ
    Am J Bioeth; 2003; 3(3):W30. PubMed ID: 14594482
    [No Abstract]   [Full Text] [Related]  

  • 15. Unconscious conflict of interest: a Jewish perspective.
    Gold A; Appelbaum PS
    J Med Ethics; 2011 Jul; 37(7):402-5. PubMed ID: 20852304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmaceutical industry has a contribution to make to evidence-based healthcare.
    Sheehy K
    N Z Med J; 2012 Jan; 125(1348):110-1. PubMed ID: 22282289
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug representatives: giving you lunch or stealing your soul?
    Higgins SP
    Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
    Mehta RS
    Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
    [No Abstract]   [Full Text] [Related]  

  • 19. The high cost of free lunch.
    Rankin RC
    Obstet Gynecol; 2007 Oct; 110(4):932. PubMed ID: 17906040
    [No Abstract]   [Full Text] [Related]  

  • 20. The high cost of free lunch.
    Randall DA
    Obstet Gynecol; 2007 Oct; 110(4):932; author reply 932-3. PubMed ID: 17906039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.